Single User License
INR 168900
Site License
INR 337800
Corporate User License
INR 506700

Service Tax Additional

select a format
Price

Single User License
USD 2500
Site License
USD 5000
Corporate User License
USD 7500

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"

Ken Research completed the report successfully with tough deadline and large requirement. Really appreciate it... "Sales Manager, Largest India Aesthetic Laser Manufacturer"

We found the report really useful in understanding the complex Indian market and it provided lots of high quality insights. On the basis of this we commissioned Ken to produce a bespoke follow up to answer some specific questions about our market. This is now being used to help develop our marketing and sales strategy. We were very pleased with the comprehensive coverage, detail provided and actionable insights.... "Owner, Therefore Consulting UK"


Helicobacter Pylori Infections Global Clinical Trials Review, H1

Helicobacter Pylori Infections Global Clinical Trials Review, H1


  Request for Sample Report

Executive Summary

Helicobacter Pylori Infections Global Clinical Trials Review, H1, 2015

GlobalData's clinical trial report, "Helicobacter Pylori Infections Global Clinical Trials Review, H1, 2015" provides an overview of Helicobacter Pylori Infections clinical trials scenario. This report provides top line data relating to the clinical trials on Helicobacter Pylori Infections. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data's proprietary database-Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

The report provides a snapshot of the global clinical trials landscape

Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

The Report provides enrollment trends for the past five years

Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons To Buy

Assists in formulating key business strategies with regards to investment

Helps in identifying prominent locations for conducting clinical trials which saves time and cost

Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

Supports understanding of trials count and enrollment trends by country in global therapeutics market

Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Introduction 6

Helicobacter Pylori Infections 6

Report Guidance 6

Clinical Trials by Region 7

Clinical Trials and Average Enrollment by Country 8

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10

Top Five Countries Contributing to Clinical Trials in Europe 11

Top Countries Contributing to Clinical Trials in North America 12

Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13

Top Five Countries Contributing to Clinical Trials in Central and South America 14

Clinical Trials by G7 Countries: Proportion of Helicobacter Pylori Infections to Infectious Disease Clinical Trials 15

Clinical Trials by Phase in G7 Countries 16

Clinical Trials in G7 Countries by Trial Status 17

Clinical Trials by E7 Countries: Proportion of Helicobacter Pylori Infections to Infectious Disease Clinical Trials 18

Clinical Trials by Phase in E7 Countries 19

Clinical Trials in E7 Countries by Trial Status 20

Clinical Trials by Phase 21

In Progress Trials by Phase 22

Clinical Trials by Trial Status 23

Clinical Trials by End Point Status 24

Unaccomplished Trials of Helicobacter Pylori Infections 25

Subjects Recruited Over a Period of Time 28

Clinical Trials by Sponsor Type 29

Prominent Sponsors 30

Top Companies Participating in Helicobacter Pylori Infections Therapeutics Clinical Trials 31

Prominent Drugs 32

Latest Clinical Trials News on Helicobacter Pylori Infections 33

Jun 08, 2015: RedHill Biopharma Completes Treatment of Last Patient with RHB-105 in Phase III Study 33

Jun 03, 2015: RedHill Biopharma Provides Update on Development Pipeline and Expected Timing for RHB-105 Phase III Top-Line Results 33

May 07, 2015: RedHill Biopharma to Host Investor Webcast Forum Following Completion of RHB-105 Dosing in Phase III Study 35

Apr 27, 2015: RedHill Biopharma Announces Completion of Patient Enrollment in a Phase III Study of RHB-105 for H. pylori Infection 35

Clinical Trial Profiles 37

Clinical Trial Overview of Top Companies 37

RedHill Biopharma Ltd. 37

Clinical Trial Overview of RedHill Biopharma Ltd. 37

AstraZeneca Plc 38

Clinical Trial Overview of AstraZeneca Plc 38

MerLion Pharmaceuticals Pte Ltd 39

Clinical Trial Overview of MerLion Pharmaceuticals Pte Ltd 39

Aspen Pharmacare Holdings Ltd 40

Clinical Trial Overview of Aspen Pharmacare Holdings Ltd 40

Takeda Pharmaceutical Company Limited 41

Clinical Trial Overview of Takeda Pharmaceutical Company Limited 41

Otsuka Holdings Co., Ltd. 42

Clinical Trial Overview of Otsuka Holdings Co., Ltd. 42

Eisai Co., Ltd. 43

Clinical Trial Overview of Eisai Co., Ltd. 43

Forest Laboratories, Inc. 44

Clinical Trial Overview of Forest Laboratories, Inc. 44

Chemo Espana, S.A. 45

Clinical Trial Overview of Chemo Espana, S.A. 45

Bluefish Pharmaceuticals AB 46

Clinical Trial Overview of Bluefish Pharmaceuticals AB 46

Clinical Trial Overview of Top Institutes / Government 47

National Taiwan University Hospital 47

Clinical Trial Overview of National Taiwan University Hospital 47

Tehran University of Medical Sciences 48

Clinical Trial Overview of Tehran University of Medical Sciences 48

Mazandaran University of Medical Sciences 49

Clinical Trial Overview of Mazandaran University of Medical Sciences 49

Keio University 50

Clinical Trial Overview of Keio University 50

Shanghai Jiao Tong University School of Medicine 51

Clinical Trial Overview of Shanghai Jiao Tong University School of Medicine 51

Buddhist Tzu Chi General Hospital 52

Clinical Trial Overview of Buddhist Tzu Chi General Hospital 52

Guilan University of Medical Sciences 53

Clinical Trial Overview of Guilan University of Medical Sciences 53

Kaohsiung Veterans General Hospital. 54

Clinical Trial Overview of Kaohsiung Veterans General Hospital. 54

The University of Tokyo Hospital 55

Clinical Trial Overview of The University of Tokyo Hospital 55

National Cancer Center 56

Clinical Trial Overview of National Cancer Center 56

Five Key Clinical Profiles 57

Appendix 75

Abbreviations 75

Definitions 75

Research Methodology 76

Secondary Research 76

About GlobalData 77

Contact Us 77

Disclaimer 77

Source 77

List of Figures

Helicobacter Pylori Infections Therapeutics, Global, Clinical Trials by Region (%), 2015* 7

Helicobacter Pylori Infections Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Helicobacter Pylori Infections Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Helicobacter Pylori Infections Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10

Helicobacter Pylori Infections Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11

Helicobacter Pylori Infections Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12

Helicobacter Pylori Infections Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2015* 13

Helicobacter Pylori Infections Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2015* 14

Proportion of Helicobacter Pylori Infections to Infectious Disease Clinical Trials, G7 Countries (%), 2015* 15

Helicobacter Pylori Infections Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Helicobacter Pylori Infections Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Helicobacter Pylori Infections to Infectious Disease Clinical Trials, E7 Countries (%), 2015* 18

Helicobacter Pylori Infections Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Helicobacter Pylori Infections Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Helicobacter Pylori Infections Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21

Helicobacter Pylori Infections Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22

Helicobacter Pylori Infections Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Helicobacter Pylori Infections Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Helicobacter Pylori Infections Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 28

Helicobacter Pylori Infections Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 29

Helicobacter Pylori Infections Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 30

Helicobacter Pylori Infections Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 31

Helicobacter Pylori Infections Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 32

GlobalData Methodology 76

List of Tables

Helicobacter Pylori Infections Therapeutics, Global, Clinical Trials by Region, 2015* 7

Helicobacter Pylori Infections Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Helicobacter Pylori Infections Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Helicobacter Pylori Infections Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10

Helicobacter Pylori Infections Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11

Helicobacter Pylori Infections Therapeutics Clinical Trials, North America, Top Countries, 2015* 12

Helicobacter Pylori Infections Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2015* 13

Helicobacter Pylori Infections Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2015* 14

Proportion of Helicobacter Pylori Infections to Infectious Disease Clinical Trials, G7 Countries (%), 2015* 15

Helicobacter Pylori Infections Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Helicobacter Pylori Infections Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Helicobacter Pylori Infections to Infectious Disease Clinical Trials, E7 Countries (%), 2015* 18

Helicobacter Pylori Infections Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Helicobacter Pylori Infections Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Helicobacter Pylori Infections Therapeutics, Global, Clinical Trials by Phase, 2015* 21

Helicobacter Pylori Infections Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22

Helicobacter Pylori Infections Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Helicobacter Pylori Infections Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Helicobacter Pylori Infections Therapeutics, Global, Suspended Clinical Trials, 2015* 25

Helicobacter Pylori Infections Therapeutics, Global, Withdrawn Clinical Trials, 2015* 26

Helicobacter Pylori Infections Therapeutics, Global, Terminated Clinical Trials, 2015* 27

Helicobacter Pylori Infections Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 28

Helicobacter Pylori Infections Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 29

Helicobacter Pylori Infections Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 30

Helicobacter Pylori Infections Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 31

Helicobacter Pylori Infections Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 32

Helicobacter Pylori Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by RedHill Biopharma Ltd., 2015* 37

Helicobacter Pylori Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca Plc, 2015* 38

Helicobacter Pylori Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by MerLion Pharmaceuticals Pte Ltd, 2015* 39

Helicobacter Pylori Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Aspen Pharmacare Holdings Ltd, 2015* 40

Helicobacter Pylori Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Takeda Pharmaceutical Company Limited, 2015* 41

Helicobacter Pylori Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Otsuka Holdings Co., Ltd., 2015* 42

Helicobacter Pylori Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Co., Ltd., 2015* 43

Helicobacter Pylori Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Forest Laboratories, Inc., 2015* 44

Helicobacter Pylori Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Chemo Espana, S.A., 2015* 45

Helicobacter Pylori Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Bluefish Pharmaceuticals AB, 2015* 46

Helicobacter Pylori Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2015* 47

Helicobacter Pylori Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Tehran University of Medical Sciences, 2015* 48

Helicobacter Pylori Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Mazandaran University of Medical Sciences, 2015* 49

Helicobacter Pylori Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Keio University, 2015* 50

Helicobacter Pylori Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Shanghai Jiao Tong University School of Medicine, 2015* 51

Helicobacter Pylori Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Buddhist Tzu Chi General Hospital, 2015* 52

Helicobacter Pylori Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Guilan University of Medical Sciences, 2015* 53

Helicobacter Pylori Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Kaohsiung Veterans General Hospital., 2015* 54

Helicobacter Pylori Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Tokyo Hospital, 2015* 55

Helicobacter Pylori Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Center, 2015* 56

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

RedHill Biopharma Ltd.

AstraZeneca Plc

MerLion Pharmaceuticals Pte Ltd

Aspen Pharmacare Holdings Ltd

Takeda Pharmaceutical Company Limited

Otsuka Holdings Co., Ltd.

Eisai Co., Ltd.

Forest Laboratories, Inc.

Chemo Espana, S.A.

Bluefish Pharmaceuticals AB

Helicobacter Pylori Infections Clinical Trials, Phase, Completed, Ongoing, Planned, End Points, Trial Locations, Trial Designs, Subjects Recruited, Safety, Efficacy, Bioequivalence, Pharmacokinetics, Pharmacodynamic, Sponsor, Collaborator, CRO's, Terminated, Suspended and Withdrawn trials of Helicobacter Pylori Infections, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas M. D. Anderson Cancer Center, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, University of Pennsylvania.


Related Products in vertical
Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com